These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Local effects of antilymphocyte serum. Halasz NA; Amonic R; Devin J; Miller S Transplant Proc; 1969 Mar; 1(1):442-4. PubMed ID: 4944257 [No Abstract] [Full Text] [Related]
43. Studies in immuno-suppression. Methods to evaluate anti-human lymphocyte sera. Balner H; Dersjant H; van Bekkum DW Transplant Proc; 1969 Mar; 1(1):629-37. PubMed ID: 5002666 [No Abstract] [Full Text] [Related]
44. Induction of immunologic tolerance to antilymphocyte globulin in man. Gewurz H; Moberg AW; Simmons RL; Pollara B; Gunnarsson A; Soll R; Najarian JS Surg Forum; 1969; 20():259-61. PubMed ID: 4986402 [No Abstract] [Full Text] [Related]
45. Effect of antilymphocyte serum on renal allograft survival in dogs with special reference to the cytotoxic titer and immunosuppressive activity. Matsukura M; Sekiguchi M; Endo S; Kurosawa T; Koishi T Jpn J Exp Med; 1971 Aug; 41(4):369-73. PubMed ID: 4936584 [No Abstract] [Full Text] [Related]
46. Depletion of lymphocytes for the protection of renal allografts. Sarles HE; Remmers AR; Fish JC; Canales CO; Thomas FD; Tyson KR; Beathard GA; Ritzmann SE Arch Intern Med; 1970 Mar; 125(3):443-50. PubMed ID: 4190497 [No Abstract] [Full Text] [Related]
48. [Serologic studies of patients under treatment with xenogenous antilymphocyte globulin]. Hopf U; Fateh-Moghadam A; Land W; Brendel W Klin Wochenschr; 1970 Aug; 48(15):906-13. PubMed ID: 4996980 [No Abstract] [Full Text] [Related]
49. Evaluation of antithymocyte serum in the treatment of canine renal homografts. Braf ZF; Smellie WA; Williams GM; Hume DM Surg Gynecol Obstet; 1969 Jul; 129(1):71-8. PubMed ID: 4892857 [No Abstract] [Full Text] [Related]
50. Factors in infectious complications following cadaver renal transplantation. Thomas F; Lee HM; Wolf JS; Thomas J Proc Clin Dial Transplant Forum; 1973; 3():196-9. PubMed ID: 4619681 [No Abstract] [Full Text] [Related]
51. Evaluation of human cultured lymphoblasts as a source of antigen for production of immunosuppressive antilymphocyte serum. Sell K; Woody J; Smith J; Darrow C; Kayhoe D Transplant Proc; 1973 Mar; 5(1):541-7. PubMed ID: 4633091 [No Abstract] [Full Text] [Related]
52. Mechanism of long term survival of renal allografts after treatment with antilymphocyte antibody. Guttmann RD; Lindquist RR; Ockner SA; Merrill JP Transplant Proc; 1969 Mar; 1(1):463-6. PubMed ID: 4944260 [No Abstract] [Full Text] [Related]
53. Lymphocyte responsiveness in cancer and transplantation. McKhann CF; Slade MS; Gunnarsson A; Burk MW Transplant Proc; 1975 Jun; 7(2):287-90. PubMed ID: 1093297 [No Abstract] [Full Text] [Related]
54. Allergic reactions to a horse globulin therapy and their prevention by induction of immunological tolerance. Ring J; Seifert J; Lob G; Hopf U; Land W; Brendel W Allergol Immunopathol (Madr); 1974; 2(2):93-8. PubMed ID: 4211785 [No Abstract] [Full Text] [Related]
56. Correlation of platelet aggregation in canine renal allotransplants with serum cytotoxic antibody following treatment with azathioprine. Lowenhaupt RW; Nathan P; Menefee MG Transplant Proc; 1971 Mar; 3(1):453-6. PubMed ID: 4937917 [No Abstract] [Full Text] [Related]
57. [Orthotopic transplantation of the liver in dogs (50 cases). Trial use of antilymphocyte serum]. Moreaux J; Huguet C; Hugier M; Martin E; Bloch P Nouv Presse Med; 1972 Jan; 1(5):338. PubMed ID: 4551595 [No Abstract] [Full Text] [Related]